Skip to Main Content

Advertisement

Skip Nav Destination

National Partner Society Abstract Achievement Awards

December 11, 2021

The National Partner Society Abstract Achievement Awards are awarded to an international hematologist, who must be a member of the supporting organization and resident of the respective country, to help advance knowledge and inspire continued professional development in hematology. The awardees can be undergraduate students, medical students, graduate students, resident physicians, or postdoctoral MD or PhD fellows. 

ASH-Haematology Society of Australia and New Zealand (HSANZ) Abstract Achievement Awards 

The ASH-HSANZ AAA is granted to up to two trainees who are first or senior author and presenter of the most meritorious country-specific project.  

Katharine Lewis, BMBS, FRCPath, MRCPath Sir Charles Gairdner Hospital 
Abstract 181 
Title: High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients 
905. Outcomes Research-Lymphoid Malignancies: Lymphoma/CLL Real-World Data 
Saturday, December 11, 2021, 12:00 p.m. Eastern time (ET) 

ASH-Japanese Society of Hematology (JSH) Abstract Achievement Awards 

The ASH-JSH AAA is granted to up to three trainees who are the first or senior author and presenter of the most meritorious country specific project. 

Yoshiaki Abe, MD University of Tsukuba 
Abstract 447 Title: A Single-Cell Atlas of Nonhematopoietic Cells in Human Lymph Node and Lymphoma Reveals Landscape of Stromal Remodeling 
622. Lymphomas: Translational–Non-Genetic: Lymphoma biology and microenvironment 
Sunday, December 12, 2021, 12:30 p.m. ET 

Koji Jimbo, MD The University of Tokyo 
Abstract 1153 Title: Deficiency of the E3 Ligase Hoip Impairs Adult Hematopoiesis and Myeloid Leukemia 
603. Oncogenes and Tumor Suppressors: Basic: Poster I 
Saturday, December 11, 2021, 5:30 p.m. ET 

June Takeda, MD Kyoto University 
Abstract 610 Title: EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia 
617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Further unraveling the genetic background of AML 
Monday, December 13, 2021, 11:15 a.m.ET 

ASH-Society Italiana di Ematologia (SIE) Abstract Achievement Awards 

The ASH-SIE AAA is granted to up to two trainees who are the first or senior author and presenter of the most meritorious country specific project. 

Annamaria Aprile, PhD IRCCS San Raffaele Scientific Institute 
Abstract 572 Title: Inhibition of Fibroblast Growth Factor-23 (FGF-23) Rescues Bone and Hematopoietic Stem Cell Niche Defects in Beta-Thalassemia, Uncovering the Missing Link between Hematopoiesis and Bone 
112. Thalassemia and Globin Gene Regulation 
Monday, December 13, 2021, 10:45 a.m. ET 

Enrica Federti, PhD University of Verona 
Abstract 3068 Title: Nrf2 Plays a Key Role in Iron-Overload Cardiomyopathy 
102. Iron Homeostasis and Biology: Poster III 
Monday, December 13, 2021, 6:00 p.m. ET 

ASH-British Society of Hematology (BSH) Abstract Achievement Award 

The ASH-BSH AAA is granted to up to three trainees who are the first or senior author and presenter of the most meritorious submitted abstract. 

Mohsin Badat, MB, Bchir University of Oxford 
Abstract 2935 Title: Base Editing Repairs the HbE Mutation Restoring the Production of Normal Globin Chains in Severe HbE/β-Thalassemia Patient Hematopoietic Stem Cells and Erythroid Cells 
801. Gene Therapies: Poster II 
Sunday, December 12, 2021, 6:00 p.m. ET 

Emily Mitchell, BA Wellcome Sanger Institute 
Abstract 598 Title: Clonal Dynamics of Normal Haematopoiesis with Human Ageing 
503. Clonal Hematopoiesis, Aging and Inflammation: Mechanisms, Disease Associations and the Impact of Aging 
Monday, December 13, 2021, 11:15 a.m. ET 

Matthew Wilson Beatson West of Scotland Cancer Centre 
Abstract 452 
Title: Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients 
627. Aggressive Lymphomas: Clinical and Epidemiological: Clinical Management of Aggressive B cell NHL 
Sunday, December 12, 2021, 12:15 p.m. ET 

To learn more about these new partner awards, and to apply for the future award cycle, visit www.hematology.org/awards/abstract-achievement. 

Close Modal

or Create an Account

Close Modal
Close Modal